New hope to avoid permanent colostomy bags? trial tests combo therapy for tough rectal cancers

This study tested whether adding an immunotherapy drug to the standard pre-surgery treatment (chemotherapy and radiation) could improve results for patients with a specific type of ultra-low rectal cancer. It involved 201 patients who were randomly assigned to receive either the standard treatment or the standard treatment plus immunotherapy. The main goal was to see if more patients could achieve a complete response to treatment, potentially avoiding major surgery and preserving their anal function.